Items where Author is "Gallagher, KE"
Up a level |
Number of items: 15.
Public
Gallagher, KE;
(2017)
Evaluating human papillomavirus vaccine introduction in
Tanzania and other low-resource settings.
PhD (research paper style) thesis, London School of Hygiene & Tropical Medicine.
DOI: https://doi.org/10.17037/PUBS.03894605
Gallagher, KE;
Baisley, K;
Grosskurth, H;
Vallely, A;
Kapiga, S;
Vandepitte, J;
Kamali, A;
De Sanjosé, S;
Changalucha, J;
Hayes, R;
+1 more...
Watson-Jones, D;
(2016)
The association between cervical human papillomavirus infection and subsequent HIV acquisition in Tanzanian and Ugandan women: a nested case-control study.
The Journal of infectious diseases, 214 (1).
pp. 87-95.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jiw094
Gallagher, KE;
Erio, T;
Baisley, K;
Lees, S;
Watson-Jones, D;
(2018)
The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
BMC health services research, 18 (1).
p. 173.
ISSN 1472-6963
DOI: https://doi.org/10.1186/s12913-018-2976-2
Gallagher, KE;
Howard, N;
Kabakama, S;
Mounier-Jack, S;
Burchett, HED;
LaMontagne, DS;
Watson-Jones, D;
(2017)
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Papillomavirus research (Amsterdam, Netherlands), 4.
pp. 72-78.
ISSN 2405-8521
DOI: https://doi.org/10.1016/j.pvr.2017.09.001
Gallagher, KE;
Howard, N;
Kabakama, S;
Mounier-Jack, S;
Griffiths, UK;
Feletto, M;
Burchett, HED;
LaMontagne, DS;
Watson-Jones, D;
(2017)
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
PloS one, 12 (6).
e0177773.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0177773
Gallagher, KE;
Kabakama, S;
Howard, N;
Mounier-Jack, S;
Griffiths, UK;
Feletto, M;
Lamontagne, DS;
Burchett, HED;
Watson-Jones, D;
(2016)
Lessons learnt from human papillomavirus (HPV) vaccine demonstration projects and national programmes in low- and middle-income countries.
Technical Report.
UNSPECIFIED.
DOI: https://doi.org/10.17037/PUBS.03351522
Gallagher, KE;
Kadokura, E;
Eckert, LO;
Miyake, S;
Mounier-Jack, S;
Aldea, M;
Ross, DA;
Watson-Jones, D;
(2016)
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.
BMC public health, 16 (1).
p. 172.
ISSN 1471-2458
DOI: https://doi.org/10.1186/s12889-016-2845-z
Gallagher, KE;
Kelly, H;
Cocks, N;
Dixon, S;
Mounier-Jack, S;
Howard, N;
Watson-Jones, D;
(2018)
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.
Papillomavirus research (Amsterdam, Netherlands).
ISSN 2405-8521
DOI: https://doi.org/10.1016/j.pvr.2018.10.004
Gallagher, KE;
LaMontagne, DS;
Watson-Jones, D;
(2018)
Status of HPV vaccine introduction and barriers to country uptake.
Vaccine.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2018.02.003
Gallagher, Katherine;
Knoll, Maria D;
Prosperi, Chrissy;
Baggett, Henry C;
Brooks, W Abdullah;
Feiken, Daniel R;
Hammitt, Laura L;
Howie, Stephen R C;
Kotloff, Karen L;
Levine, Orin S;
+19 more...
Madhi, Shabir A;
Murdoch, David R;
O’Brien, Katherine L;
Thea, Donald M;
Awori, Juliet O;
Baillie, Vicky L;
Ebruke, Bernard Eseoghene;
Goswami, Doli;
Kamau, Alice;
Maloney, Susan A;
Moore, David P;
Mwananyanda, Lawrence;
Olutunde, Emmanuel O;
Seidenberg, Phil;
Sissoko, Seydou;
Sylla, Mamadou;
Thamthitiwat, Somsak;
Zaman, Khalequ;
Scott, J Anthony G;
(2019)
The predictive performance of a pneumonia severity score in HIV-negative children presenting to hospital in seven low and middle-income countries.
Clinical Infectious Diseases.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciz350
Gallagher, K.K., H;
Cocks, N;
Mounier-Jack, S;
Dixon, S;
Howard, N;
Watson-Jones, D;
Scoping Views On A Single Dose Human Papillomavirus (Hpv) Vaccin, IncomeCountries;
(2018)
Scoping views on a single dose human papillomavirus (HPV) vaccine schedule amongst policy makers in low and middle-income countries.
Technical Report.
London School of Hygiene & Tropical Medicine.
DOI: https://doi.org/10.17037/PUBS.04649924
Howard, N;
Gallagher, KE;
Mounier-Jack, S;
Burchett, HED;
Kabakama, S;
LaMontagne, DS;
Watson-Jones, D;
(2017)
What works for human papillomavirus vaccine introduction in low and middle-income countries?
Papillomavirus research (Amsterdam, Netherlands), 4.
pp. 22-25.
ISSN 2405-8521
DOI: https://doi.org/10.1016/j.pvr.2017.06.003
Howard, N;
Mounier-Jack, S;
Gallagher, KE;
Kabakama, S;
Griffiths, UK;
Feletto, M;
LaMontagne, DS;
Burchett, HE;
Watson-Jones, D;
(2016)
The value of demonstration projects for new interventions: the case of human papillomavirus vaccine introduction in low and middle-income countries.
Human vaccines & immunotherapeutics.
pp. 1-3.
ISSN 2164-5515
DOI: https://doi.org/10.1080/21645515.2016.1178433
Kabakama, S;
Gallagher, KE;
Howard, N;
Mounier-Jack, S;
Burchett, HE;
Griffiths, UK;
Feletto, M;
LaMontagne, DS;
Watson-Jones, D;
(2016)
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.
BMC public health, 16 (1).
p. 834.
ISSN 1471-2458
DOI: https://doi.org/10.1186/s12889-016-3517-8
LaMontagne, DS;
Bloem, PJN;
Brotherton, JML;
Gallagher, KE;
Badiane, O;
Ndiaye, C;
(2017)
Progress in HPV vaccination in low- and lower-middle-income countries.
International journal of gynaecology and obstetrics, 138 Su.
pp. 7-14.
ISSN 0020-7292
DOI: https://doi.org/10.1002/ijgo.12186